Background: Free amino acids and acylcarnitines circulating in the blood can be used for diagnosis for metabolic illness and imbalances. To date, the normal reference ranges of amino acids and acylcarnitines in horse peripheral blood have not been established. In this study, the concentrations of 12 amino acids and 26 acylcarnitines were determined by tandem mass spectrometry in complete blood from 100 healthy horses (50 Quarter horses (QH) [23 males and 27 females] and 50 American Miniature horses (AMH) [15 males and 35 females]) with no signs of metabolic disease. The means and standard deviations were determined and data statistically analyzed.
Findings
Analysis of free amino acids and acylcarnitines circulating in blood is a powerful diagnostic tool for metabolic illnesses and imbalances [1] ; conditions that have an economic impact in the equine sector [2] . Reference ranges for these compounds have been established for obese rats, adult canines and even for plants by tandem mass spectrometry (MS/MS) [3] [4] [5] and atypical myopathies have been identified in horses (Equus caballus) using this technology [6] . Metabolic disorders are common in horses, and can be categorized as disorders of carbohydrate metabolism [7] , lipid disorders [8] , purine disorders [9] , and primary disorders of electrolytic flux [10] . Diet [11] and metabolic disorders are important factors affecting amino acid and acylcarnitine concentrations in horses [12] .
We hypothesized that concentrations of amino acids and acylcarnitines in the blood are different between Quarter horses (QH) and American Miniature horses (AMH). This study reports the concentrations of these compounds in peripheral blood of normal horse of both Open Access *Correspondence: iramrodriguez@gmail.com 1 Departamento de Genética, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, Mexico Full list of author information is available at the end of the article gender and establishes normal reference ranges for these breeds.
The research protocol was approved by the Institutional Committee for the Act # 2 (Approbation code FMVZ-CBA-002). A total of 100 clinically normal horses [50 QH (23 males and 27 females) and 50 AMH (15 males and 35 females)] from several stud farms and riding stables in the cities of Monterrey, Nuevo León and Cuatrociénegas, Coahuila, northeastern Mexico were selected. The horses were fed twice a day with dry forage (2.2 % of their body weight) and commercial cereals, molasses, oilseeds, vitamins and minerals (0.5 % of their body weight), and water ad libitum. The horses were used in racing, rodeos, or kept as pets. Age and weight ranges are shown in detail in Additional file 1.
Complete blood was collected 3-5 h after first food ingestion in the morning from the jugular vein using a vacutainer tube with no anticoagulant and a 21G × 1.5″ size needle; posteriorly one drop of blood was placed on each of five filter paper circles (S&S 903, Whatman, Little Chalfont, UK) using a pipette. The filter papers were then dried for 3 h at room temperature avoiding exposure to sunlight.
Each sample was analyzed for 12 amino acids and 26 acylcarnitines (Fig. 1) 
Statistical analysis was performed using R (http://www. cran.r-project.org/). To normalize the raw measurements, we set the sum of all values within a sample to 1. This was achieved by dividing each value by the sum of all values per sample. These normalized values were then converted to logarithms to handle extreme values. A t test was used to determine statistically significant differences between groups. Corrections of q-values were made for multiple tests using a false discovery rate approach and P ≤ 0.05 were considered as significant. For correlation analyses, absolute Pearson correlations ≥0.7 were used.
Normal reference ranges were established for 12 amino acids and 26 acylcarnitines in blood of AMH and QH. Mean values, standard deviation, maximum and minimum values for each metabolite are provided in Additional file 2 for each breed and gender. Among the 38 metabolites (Fig. 1) , the concentrations of 16 were significantly different between the horse breeds (indicated by * Table 1 ).
Comparisons by gender between breeds (female quarters vs female miniatures, and the same for males) were statistically significant for both males and females (Table 1 ; Fig. 1 ), but not within the same breed. For male horses, concentrations of C2, C3, C5, C8, C14, C14:1, C:16 and C16:1 were significantly higher in AMH than in QH. Only C18:1 was higher in male QH than in male AMH. The concentrations of the amino acids Ala, Arg, Gly, Pro and Leu were significantly higher in QH than in AMH, while the concentrations of Val was higher in AMH than in QH. For the female horses, the concentrations of C3, Leu, Pro and Arg were significantly higher in AMH than in QH. Inversely, Val and Orn were higher in QH than in AMH (Table 1 ; Fig. 1 ).
In the present study, horse breeds showed differences in acylcarnitine concentrations, which could be caused by variation in daily physical activity, individual genetics, or environmental factors. Diet is a factor that affects blood concentrations of amino acids, hormones, proteins, and other circulating compounds [11] . In the present study, horses were fed the same ration based on their individual weight, so the effects of diet on the obtained values is considered minimal. QH showed higher Leu concentrations than AMH and conversely Val concentrations were higher in male AMH than in male QH. These differences may reflect metabolic differences between breeds. Analysis of samples from other breeds may clarify this. If the differences depend on breed, this factor should be taken into account in the interpretation of the results for the possible diagnosis of metabolic disorders.
In conclusion, normal reference ranges were established for amino acids and acylcarnitines in QH and AMH. The established ranges could be used to diagnose metabolic abnormalities that affect the performance of horses of high sporting and economic value. Positive results can be followed up with more specific testing for confirmation of the diagnosis. 
